Home

FAST REACTION TIME

6X faster, annihilating 5M+ bacteria in 20 mins.

UNRIVALLED STABILITY

Clinically proven adhesion and mechanical stability.

EXTREME DURABILITY

10X more durable than existing technology.

KILL ALL MICROBIAL THREATS

Including all bacteria, MDR strains, fungi and virus.

When modern medicines lose their power

AMR/MDR, THE GLOBAL THREAT

Imagine a world where common infections are untreatable. This is the stark reality we face with this slow motion pandemic. An invisible adversary which is currently turning our medical victories into looming defeats.

Our mission is clear: to safeguard humanity from this invisible enemy.

COLLATERAL CONTAMINATION

ENVIRONMENT 100%
WATER 100%
FOOD 100%
ANIMAL 100%

By 2050, AMR/MDR is set to eclipse cancer in fatalities, with a death every three seconds. It will pose THE greatest threat to human health within the next few years”, said WHO latest report.

The ripple effects are staggering: It forecasts a $100 trillion global economic blow by 2030, pushing 24 million into extreme poverty.

This crisis extends beyond health boundaries with collateral contamination.

This isn’t just a global health crisis; it’s a call to decisive action.

Innovating for a World Free from Microbial Threats

TRANSFORMING SURFACES, PROTECTING LIVES

Emerging from EPFL’s innovative ecosystem in 2016, IbtiCare has redefined over the past years antibacterial technology. Our pioneering Physical Vapor Deposition (PVD) process embeds advanced nanoparticles onto surfaces, bestowing them with powerful antibacterial properties.

Deep dive into the world of IbtiCare, where our advanced nanotechnology-based coatings ensures every touch is a touch of safety.

Unique Physical Properties

  • High uniformity
  • Strong adhesion
  • High mechanical stability
  • No toxicity
  • No chemical process applied

Successful Clinical Tested

  • Tested on multi-drug resistant bacteria
  • Tested on fresh human skin
  • Tested for durability by washing, using ICP-MS
  • Tested for materials chemistry at the interface

TRUSTED BY INDUSTRY LEADERS AND BACKED BY GROUNBREAKING RESEARCH

IbtiCare: A Journey of Innovation and Excellence

From a visionary SNSF grant in 2013 to a patented PVD technology and clinical triumphs, we're redefining global health safety and sustainability.

2013

The Genesis

IbtiCare's journey began with a significant SNSF grant of 0.6 million CHF, marking the inception of a groundbreaking project in healthcare technology.

2014

Pioneering Technology

Development of a novel Physical Vapor Deposition (PVD) machine, a cornerstone in IbtiCare's innovative approach.

2015

Intellectual Milestone

IbtiCare achieved a significant milestone by securing a patent for its revolutionary technology, setting a new standard in the field.

2016

Clinical Validation

Intensive clinical trials validate the technology's effectiveness and safety.

2020

Industrial Leap

The culmination of years of research and development led to an industrial-scale prototype, reshaping global healthcare.

2022

Structuring and Growth

Ongoing growth and innovation, fueled by strategic investments, cementing IbtiCare's leadership in antibacterial tech.

  • Lead
  • The
  • Nano-Coating
  • Revolution
  • Antibacterial.
  • Antifungal.
  • Antiviral.

Award-Winning Innovation

+ 6

PIPELINE
CO-DEVELOPMENT, INDUSTRY PARTNERSHIPS

+ 6

AWARDS
FROM PRESTIGIOUS SPONSORS

+ 150

REFERRAL SCIENCE PUBLICATIONS
AMONG THE MOST RANKED ARTICLES WORLDWIDE

Revolutionizing the fight against AMR/MDR

IbtiCare: Invisible Armor, Visible Impact

  • Lead
  • The
  • Nano-Coating
  • Revolution
  • Antibacterial.
  • Antifungal.
  • Antiviral.

Where every surface is a shield for health!

Experience the transformative power of IbtiCare